Looking for distribution partners in Europe, Asia and the US for highly reliable molecular in vitro diagnostic (IVD) test for screening, triage and follow-up care in cervical cancer diagnostics
A young German SME specialized in molecular biology and cancer diagnostics has developed a fast and reliable diagnostic test based on epigenetic changes (DNA methylation) which are characteristic for cancer cells. These highly informative biomarkers validated in clinical trials and applicable for early detection of cervical cancer. Corresponding marker sets for head-and-neck tumor and ovarian cancer are also validated. Seeking medical partners for licensing and technical cooperation agreements.